These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 14636027)
21. Multi-scale mathematical modelling of tumour growth and microenvironments in anti-angiogenic therapy. Cai Y; Zhang J; Li Z Biomed Eng Online; 2016 Dec; 15(Suppl 2):155. PubMed ID: 28155728 [TBL] [Abstract][Full Text] [Related]
22. Mathematical modeling of the onset of capillary formation initiating angiogenesis. Levine HA; Sleeman BD; Nilsen-Hamilton M J Math Biol; 2001 Mar; 42(3):195-238. PubMed ID: 11315313 [TBL] [Abstract][Full Text] [Related]
23. A mathematical model of angiogenesis and tumor growth: analysis and application in anti-angiogenesis therapy. Zheng X; Sweidan M J Math Biol; 2018 Nov; 77(5):1589-1622. PubMed ID: 30019238 [TBL] [Abstract][Full Text] [Related]
24. Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro. Hamsa TP; Kuttan G Eur J Pharmacol; 2010 Dec; 649(1-3):64-73. PubMed ID: 20858484 [TBL] [Abstract][Full Text] [Related]
25. Role of angiogenesis in tumor growth and metastasis. Folkman J Semin Oncol; 2002 Dec; 29(6 Suppl 16):15-8. PubMed ID: 12516034 [TBL] [Abstract][Full Text] [Related]
26. Mathematical modelling of tumour-induced angiogenesis: network growth and structure. Chaplain M; Anderson A Cancer Treat Res; 2004; 117():51-75. PubMed ID: 15015552 [TBL] [Abstract][Full Text] [Related]
27. Coupled modelling of tumour angiogenesis, tumour growth and blood perfusion. Cai Y; Xu S; Wu J; Long Q J Theor Biol; 2011 Jun; 279(1):90-101. PubMed ID: 21392511 [TBL] [Abstract][Full Text] [Related]
28. Tumour-Endothelial Cell Communications: Important and Indispensable Mediators of Tumour Angiogenesis. Lopes-Bastos BM; Jiang WG; Cai J Anticancer Res; 2016 Mar; 36(3):1119-26. PubMed ID: 26977007 [TBL] [Abstract][Full Text] [Related]
29. Convected element method for simulation of angiogenesis. Pindera MZ; Ding H; Chen Z J Math Biol; 2008 Oct; 57(4):467-95. PubMed ID: 18365201 [TBL] [Abstract][Full Text] [Related]
30. A heterogeneous in vitro three dimensional model of tumour-stroma interactions regulating sprouting angiogenesis. Correa de Sampaio P; Auslaender D; Krubasik D; Failla AV; Skepper JN; Murphy G; English WR PLoS One; 2012; 7(2):e30753. PubMed ID: 22363483 [TBL] [Abstract][Full Text] [Related]
31. A mathematical model of the first steps of tumour-related angiogenesis: capillary sprout formation and secondary branching. Orme ME; Chaplain MA IMA J Math Appl Med Biol; 1996 Jun; 13(2):73-98. PubMed ID: 8671581 [TBL] [Abstract][Full Text] [Related]
32. Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors. Dirkx AE; oude Egbrink MG; Castermans K; van der Schaft DW; Thijssen VL; Dings RP; Kwee L; Mayo KH; Wagstaff J; Bouma-ter Steege JC; Griffioen AW FASEB J; 2006 Apr; 20(6):621-30. PubMed ID: 16581970 [TBL] [Abstract][Full Text] [Related]
33. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas. Wong ML; Prawira A; Kaye AH; Hovens CM J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134 [TBL] [Abstract][Full Text] [Related]
34. Angiogenesis inhibition by angiostatin, endostatin and TNP-470 prevents cyclophosphamide induced cystitis. Beecken WD; Engl T; Blaheta R; Bentas W; Achilles EG; Jonas D; Shing Y; Camphausen K Angiogenesis; 2004; 7(1):69-73. PubMed ID: 15302998 [TBL] [Abstract][Full Text] [Related]
35. Tumour vascularization: sprouting angiogenesis and beyond. Hillen F; Griffioen AW Cancer Metastasis Rev; 2007 Dec; 26(3-4):489-502. PubMed ID: 17717633 [TBL] [Abstract][Full Text] [Related]
36. Mathematical modelling of angiogenesis. Chaplain MA J Neurooncol; 2000; 50(1-2):37-51. PubMed ID: 11245280 [TBL] [Abstract][Full Text] [Related]
37. A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors. Shimamura M; Nagasawa H; Ashino H; Yamamoto Y; Hazato T; Uto Y; Hori H; Inayama S Br J Cancer; 2003 Jan; 88(2):307-13. PubMed ID: 12610518 [TBL] [Abstract][Full Text] [Related]
38. Mathematical modeling of tumor-induced angiogenesis. Chaplain MA; McDougall SR; Anderson AR Annu Rev Biomed Eng; 2006; 8():233-57. PubMed ID: 16834556 [TBL] [Abstract][Full Text] [Related]
39. Tumor angiogenesis and anti-angiogenic therapies. Shahneh FZ; Baradaran B; Zamani F; Aghebati-Maleki L Hum Antibodies; 2013; 22(1-2):15-9. PubMed ID: 24284305 [TBL] [Abstract][Full Text] [Related]